top of page
​
Clinical Development
Pipeline
Based on robust preclinical data and on largely admitted safety of WhartSep, StemInov is preparing a phase Ib/IIa trial in severe pneumonia patients admitted in ICU
Preclinical Studies
bottom of page
​
Based on robust preclinical data and on largely admitted safety of WhartSep, StemInov is preparing a phase Ib/IIa trial in severe pneumonia patients admitted in ICU